BREXIT STATEMENT

The decision made by the UK to leave the European Union, or ‘Brexit’ as it has become known, means that we must embrace the challenges that this decision will bring.

Inevitably there is still a great deal of uncertainty as the Brexit negotiations continue to take place and therefore it is impossible to predict the final outcome.

Nova Laboratories routinely import and export medicines both within and outside of the EU. We are well versed in the necessary procedures.  We hold an Economic Operator Registration and Identification (EORI) number which is required to import and export goods from the EU. We are currently in partnership with FedEx who can support us with any extra requirements relating to customs clearance entries and exit and entry summary declarations.

Here is a link to the FedEx Brexit information page on their website. https://www.fedex.com/en-gb/about/brexit.html
Nova Laboratories raw ingredient stock levels are planned 6 months in advance based on historical data to ensure that we are able to manufacture our products as we do today. The products imported from mainland Europe and non-EU countries come via a well-established process and robust supply chain.

We understand that many customers have concerns and the Nova Customer Services team are available to help if we can.  Please contact us on [email protected] and we will do our best to assist you. Please be assured that we are taking all reasonable steps to mitigate risk where it is within our control. We will continue to review our position as more information is provided by the Government and this will be updated on the home page under latest news on our website. https://www.novalabs.co.uk